Provided by Tiger Trade Technology Pte. Ltd.

Arcturus Therapeutics Ltd.

7.57
+0.55007.83%
Post-market: 7.570.00000.00%19:50 EST
Volume:570.36K
Turnover:4.21M
Market Cap:215.08M
PE:-3.08
High:7.63
Open:7.24
Low:7.01
Close:7.02
52wk High:24.17
52wk Low:5.85
Shares:28.41M
Float Shares:26.28M
Volume Ratio:1.14
T/O Rate:2.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4611
EPS(LYR):-2.9978
ROE:-27.43%
ROA:-15.00%
PB:0.96
PE(LYR):-2.53

Loading ...

Arcturus’ ARCT-2304 Flu Vaccine Trial Reaches Phase 1 Finish Line: What Investors Should Watch Next

TIPRANKS
·
Jan 31

Analysts Are Bullish on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Cerus (CERS)

TIPRANKS
·
Jan 24

Arcturus Therapeutics initiated with a Buy at Roth Capital

TIPRANKS
·
Jan 23

Analysts Conflicted on These Healthcare Names: Arcturus Therapeutics (ARCT), Newron Pharmaceuticals SpA (OtherNWPHF) and Aldeyra Therapeutics (ALDX)

TIPRANKS
·
Jan 21

Does Arcturus Therapeutics (ARCT) JPM Conference Spotlight Clarify Its Long-Term Platform Credibility?

Simply Wall St.
·
Jan 14

Arcturus Therapeutics CEO to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 09

Arcturus Therapeutics Holdings Inc : Citigroup Cuts Target Price to $7 From $9

THOMSON REUTERS
·
Jan 06

U.S. RESEARCH ROUNDUP-Brunswick, Parker-Hannifin, XPLR Infrastructure

Reuters
·
Jan 06

UK's Mhra: Approved Zapomeran (Kostaive) Mrna Covid-19 Vaccine, for Immunisation of Individuals Aged 18 Years and Older

THOMSON REUTERS
·
Jan 02

BRIEF-Arcturus Therapeutics Holdings Files For Mixed Shelf Of Up To $500 Million - SEC Filing

Reuters
·
Dec 31, 2025

Arcturus Therapeutics Files $500 Million Mixed Shelf

MT Newswires Live
·
Dec 31, 2025

Arcturus Therapeutics Files Initial Beneficial Ownership Statement for Controller Joseph Roberts

Reuters
·
Dec 20, 2025

BRIEF-Arcturus Therapeutics CFO Andy Sassine To Leave Company

Reuters
·
Dec 15, 2025

Arcturus Therapeutics Holdings Inc - CFO Andy Sassine to Leave Company - SEC Filing

THOMSON REUTERS
·
Dec 15, 2025

Arcturus Therapeutics Updates CFO Severance and Stock Option Terms

Reuters
·
Dec 15, 2025

Arcturus Therapeutics Holdings Inc. reports 59% revenue decline for Q3 2025

Reuters
·
Nov 12, 2025

Arcturus Therapeutics Delays Financial Report Filing

Reuters
·
Nov 12, 2025

Arcturus Therapeutics Q3 Collaboration Revenue USD 14.153 Million

THOMSON REUTERS
·
Nov 11, 2025

Arcturus Therapeutics reports third quarter revenue of $17.2 million and net loss of $13.5 million

Reuters
·
Nov 11, 2025

Arcturus Therapeutics Holdings Inc -Additional Cost Reductions Planned in Q4 to Extend Cash Runway

THOMSON REUTERS
·
Nov 11, 2025